Patent 9763933 was granted and assigned to Purdue Pharma on September, 2017 by the United States Patent and Trademark Office.
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.